Company Profile
Rallybio Stock Price, News & Analysis
- Ticker:
- RLYB
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
15.89 USD (+1.02%)
Close
Last updated: July 13, 2026 at 00:00
91.23M USD
Market cap
Why the stock is moving
RLYB is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Rallybio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Rallybio is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Rallybio follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Rallybio sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 02
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
- 03
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
BMY · Source: BMYBristol-Myers Squibb Company
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Rallybio (RLYB)?
Rallybio (RLYB) most recently closed at 15.89 USD, a +1.02% move versus the previous session.
What is the market cap of Rallybio (RLYB)?
Rallybio currently has a market capitalization of 91.23M USD on BioPharmSignal.
What does Rallybio do?
Rallybio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is RLYB stock listed?
Rallybio (RLYB) is associated with NASDAQ, United States, Biotechnology.
What is Rallybio?
Rallybio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Rallybio targeting with Rallybio?
Rallybio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.